Journal
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 156, Issue 5, Pages 635-638Publisher
SPRINGER
DOI: 10.1007/s10517-014-2413-4
Keywords
-
Categories
Funding
- Federal Agency for Science and Innovation under Federal Target Scientific and Technical Program Research and Development in Priority Areas of Scientific and Technological Complex of Russia [02.527.11.0007]
Ask authors/readers for more resources
The study included patients with type 2 diabetes mellitus and impaired carbohydrate tolerance associated with arterial hypertension, patients with arterial hypertension, and healthy volunteers. We evaluated the levels of matrix metalloproteinases 2 and 9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase type 1 (TIMP-1), glucose, insulin, C-peptide, glycated hemoglobin, and spontaneous and mitogen-activated cytokine secretion (IL-2, IL4, IL-6, IL-10, IL-17, TNF-alpha, and IFN-gamma). Patients with type 2 diabetes mellitus in combination with arterial hypertension exhibited maximum TIMP-1 levels and TIMP-1/MMP-2, TIMP-1/ MMP-9 ratios as well as enhanced secretion of TNF-alpha, IL-6, IL-17 and reduced secretion of IL-10 in comparison with healthy individuals. The observed shifts are probably determined the development of systemic hyperinsulinemia in patients suffering from type 2 diabetes mellitus coupled with arterial hypertension.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available